- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
According to our latest study, the global Cardiovascular and Cerebrovascular API market size was valued at USD 3161.7 million in 2022 and is forecast to a readjusted size of USD 3779.8 million by 2029 with a CAGR of 2.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.
The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.
This report is a detailed and comprehensive analysis for global Cardiovascular and Cerebrovascular API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cardiovascular and Cerebrovascular API market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular and Cerebrovascular API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular and Cerebrovascular API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical and Zhejiang Hisun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cardiovascular and Cerebrovascular API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sartans Cardiovascular and Cerebrovascular API
Statins Cardiovascular and Cerebrovascular API
Puri Cardiovascular and Cerebrovascular API
Market segment by Application
Oral Drugs
Injection Drugs
Major players covered
Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Lepu Pharmaceutical
Zhejiang Jiangbei Pharmaceutical
DR.Reddy
Glenmerk
Cipla
MSN Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiovascular and Cerebrovascular API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular and Cerebrovascular API, with price, sales, revenue and global market share of Cardiovascular and Cerebrovascular API from 2018 to 2023.
Chapter 3, the Cardiovascular and Cerebrovascular API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular and Cerebrovascular API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiovascular and Cerebrovascular API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular and Cerebrovascular API.
Chapter 14 and 15, to describe Cardiovascular and Cerebrovascular API sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cardiovascular and Cerebrovascular API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiovascular and Cerebrovascular API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sartans Cardiovascular and Cerebrovascular API
1.3.3 Statins Cardiovascular and Cerebrovascular API
1.3.4 Puri Cardiovascular and Cerebrovascular API
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiovascular and Cerebrovascular API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oral Drugs
1.4.3 Injection Drugs
1.5 Global Cardiovascular and Cerebrovascular API Market Size & Forecast
1.5.1 Global Cardiovascular and Cerebrovascular API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cardiovascular and Cerebrovascular API Sales Quantity (2018-2029)
1.5.3 Global Cardiovascular and Cerebrovascular API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zhuhai Rundu Pharmaceutical
2.1.1 Zhuhai Rundu Pharmaceutical Details
2.1.2 Zhuhai Rundu Pharmaceutical Major Business
2.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
2.2 Ningbo Menovo Pharmaceutical
2.2.1 Ningbo Menovo Pharmaceutical Details
2.2.2 Ningbo Menovo Pharmaceutical Major Business
2.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
2.3 Zhejiang Huahai Pharmaceutical
2.3.1 Zhejiang Huahai Pharmaceutical Details
2.3.2 Zhejiang Huahai Pharmaceutical Major Business
2.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.4 Zhejiang Tianyu Pharmaceutical
2.4.1 Zhejiang Tianyu Pharmaceutical Details
2.4.2 Zhejiang Tianyu Pharmaceutical Major Business
2.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
2.5 Zhejiang Hisun Pharmaceutical
2.5.1 Zhejiang Hisun Pharmaceutical Details
2.5.2 Zhejiang Hisun Pharmaceutical Major Business
2.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
2.6 Zhejiang Lepu Pharmaceutical
2.6.1 Zhejiang Lepu Pharmaceutical Details
2.6.2 Zhejiang Lepu Pharmaceutical Major Business
2.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zhejiang Lepu Pharmaceutical Recent Developments/Updates
2.7 Zhejiang Jiangbei Pharmaceutical
2.7.1 Zhejiang Jiangbei Pharmaceutical Details
2.7.2 Zhejiang Jiangbei Pharmaceutical Major Business
2.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
2.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates
2.8 DR.Reddy
2.8.1 DR.Reddy Details
2.8.2 DR.Reddy Major Business
2.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Product and Services
2.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 DR.Reddy Recent Developments/Updates
2.9 Glenmerk
2.9.1 Glenmerk Details
2.9.2 Glenmerk Major Business
2.9.3 Glenmerk Cardiovascular and Cerebrovascular API Product and Services
2.9.4 Glenmerk Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Glenmerk Recent Developments/Updates
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Cardiovascular and Cerebrovascular API Product and Services
2.10.4 Cipla Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cipla Recent Developments/Updates
2.11 MSN Life Sciences
2.11.1 MSN Life Sciences Details
2.11.2 MSN Life Sciences Major Business
2.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Product and Services
2.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MSN Life Sciences Recent Developments/Updates
3 Competitive Environment: Cardiovascular and Cerebrovascular API by Manufacturer
3.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer (2018-2023)
3.3 Global Cardiovascular and Cerebrovascular API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cardiovascular and Cerebrovascular API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cardiovascular and Cerebrovascular API Manufacturer Market Share in 2022
3.4.2 Top 6 Cardiovascular and Cerebrovascular API Manufacturer Market Share in 2022
3.5 Cardiovascular and Cerebrovascular API Market: Overall Company Footprint Analysis
3.5.1 Cardiovascular and Cerebrovascular API Market: Region Footprint
3.5.2 Cardiovascular and Cerebrovascular API Market: Company Product Type Footprint
3.5.3 Cardiovascular and Cerebrovascular API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cardiovascular and Cerebrovascular API Market Size by Region
4.1.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2029)
4.1.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2029)
4.1.3 Global Cardiovascular and Cerebrovascular API Average Price by Region (2018-2029)
4.2 North America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
4.3 Europe Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
4.4 Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
4.5 South America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
4.6 Middle East and Africa Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
5.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Type (2018-2029)
5.3 Global Cardiovascular and Cerebrovascular API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
6.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Application (2018-2029)
6.3 Global Cardiovascular and Cerebrovascular API Average Price by Application (2018-2029)
7 North America
7.1 North America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
7.2 North America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
7.3 North America Cardiovascular and Cerebrovascular API Market Size by Country
7.3.1 North America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
7.3.2 North America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
8.2 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
8.3 Europe Cardiovascular and Cerebrovascular API Market Size by Country
8.3.1 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
8.3.2 Europe Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cardiovascular and Cerebrovascular API Market Size by Region
9.3.1 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
10.2 South America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
10.3 South America Cardiovascular and Cerebrovascular API Market Size by Country
10.3.1 South America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
10.3.2 South America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cardiovascular and Cerebrovascular API Market Size by Country
11.3.1 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cardiovascular and Cerebrovascular API Market Drivers
12.2 Cardiovascular and Cerebrovascular API Market Restraints
12.3 Cardiovascular and Cerebrovascular API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cardiovascular and Cerebrovascular API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiovascular and Cerebrovascular API
13.3 Cardiovascular and Cerebrovascular API Production Process
13.4 Cardiovascular and Cerebrovascular API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiovascular and Cerebrovascular API Typical Distributors
14.3 Cardiovascular and Cerebrovascular API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Cardiovascular and Cerebrovascular API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cardiovascular and Cerebrovascular API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zhuhai Rundu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Zhuhai Rundu Pharmaceutical Major Business
Table 5. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 6. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zhuhai Rundu Pharmaceutical Recent Developments/Updates
Table 8. Ningbo Menovo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Ningbo Menovo Pharmaceutical Major Business
Table 10. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 11. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ningbo Menovo Pharmaceutical Recent Developments/Updates
Table 13. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Zhejiang Huahai Pharmaceutical Major Business
Table 15. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 16. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 18. Zhejiang Tianyu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Zhejiang Tianyu Pharmaceutical Major Business
Table 20. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 21. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
Table 23. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Hisun Pharmaceutical Major Business
Table 25. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 26. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 28. Zhejiang Lepu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Zhejiang Lepu Pharmaceutical Major Business
Table 30. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 31. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zhejiang Lepu Pharmaceutical Recent Developments/Updates
Table 33. Zhejiang Jiangbei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Zhejiang Jiangbei Pharmaceutical Major Business
Table 35. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
Table 36. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates
Table 38. DR.Reddy Basic Information, Manufacturing Base and Competitors
Table 39. DR.Reddy Major Business
Table 40. DR.Reddy Cardiovascular and Cerebrovascular API Product and Services
Table 41. DR.Reddy Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. DR.Reddy Recent Developments/Updates
Table 43. Glenmerk Basic Information, Manufacturing Base and Competitors
Table 44. Glenmerk Major Business
Table 45. Glenmerk Cardiovascular and Cerebrovascular API Product and Services
Table 46. Glenmerk Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Glenmerk Recent Developments/Updates
Table 48. Cipla Basic Information, Manufacturing Base and Competitors
Table 49. Cipla Major Business
Table 50. Cipla Cardiovascular and Cerebrovascular API Product and Services
Table 51. Cipla Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cipla Recent Developments/Updates
Table 53. MSN Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. MSN Life Sciences Major Business
Table 55. MSN Life Sciences Cardiovascular and Cerebrovascular API Product and Services
Table 56. MSN Life Sciences Cardiovascular and Cerebrovascular API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. MSN Life Sciences Recent Developments/Updates
Table 58. Global Cardiovascular and Cerebrovascular API Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 59. Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Cardiovascular and Cerebrovascular API Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 61. Market Position of Manufacturers in Cardiovascular and Cerebrovascular API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Cardiovascular and Cerebrovascular API Production Site of Key Manufacturer
Table 63. Cardiovascular and Cerebrovascular API Market: Company Product Type Footprint
Table 64. Cardiovascular and Cerebrovascular API Market: Company Product Application Footprint
Table 65. Cardiovascular and Cerebrovascular API New Market Entrants and Barriers to Market Entry
Table 66. Cardiovascular and Cerebrovascular API Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2023) & (MT)
Table 68. Global Cardiovascular and Cerebrovascular API Sales Quantity by Region (2024-2029) & (MT)
Table 69. Global Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Cardiovascular and Cerebrovascular API Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Cardiovascular and Cerebrovascular API Average Price by Region (2018-2023) & (USD/Kg)
Table 72. Global Cardiovascular and Cerebrovascular API Average Price by Region (2024-2029) & (USD/Kg)
Table 73. Global Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 74. Global Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 75. Global Cardiovascular and Cerebrovascular API Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Cardiovascular and Cerebrovascular API Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Cardiovascular and Cerebrovascular API Average Price by Type (2018-2023) & (USD/Kg)
Table 78. Global Cardiovascular and Cerebrovascular API Average Price by Type (2024-2029) & (USD/Kg)
Table 79. Global Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 80. Global Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 81. Global Cardiovascular and Cerebrovascular API Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Cardiovascular and Cerebrovascular API Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Cardiovascular and Cerebrovascular API Average Price by Application (2018-2023) & (USD/Kg)
Table 84. Global Cardiovascular and Cerebrovascular API Average Price by Application (2024-2029) & (USD/Kg)
Table 85. North America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 86. North America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 87. North America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 88. North America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 89. North America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2023) & (MT)
Table 90. North America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2024-2029) & (MT)
Table 91. North America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Cardiovascular and Cerebrovascular API Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 94. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 95. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 96. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 97. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2023) & (MT)
Table 98. Europe Cardiovascular and Cerebrovascular API Sales Quantity by Country (2024-2029) & (MT)
Table 99. Europe Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Cardiovascular and Cerebrovascular API Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 102. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 103. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 104. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 105. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2023) & (MT)
Table 106. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Region (2024-2029) & (MT)
Table 107. Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 110. South America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 111. South America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 112. South America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 113. South America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2023) & (MT)
Table 114. South America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2024-2029) & (MT)
Table 115. South America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Cardiovascular and Cerebrovascular API Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2023) & (MT)
Table 118. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Type (2024-2029) & (MT)
Table 119. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2023) & (MT)
Table 120. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Application (2024-2029) & (MT)
Table 121. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2023) & (MT)
Table 122. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Region (2024-2029) & (MT)
Table 123. Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Cardiovascular and Cerebrovascular API Raw Material
Table 126. Key Manufacturers of Cardiovascular and Cerebrovascular API Raw Materials
Table 127. Cardiovascular and Cerebrovascular API Typical Distributors
Table 128. Cardiovascular and Cerebrovascular API Typical Customers
List of Figures
Figure 1. Cardiovascular and Cerebrovascular API Picture
Figure 2. Global Cardiovascular and Cerebrovascular API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Type in 2022
Figure 4. Sartans Cardiovascular and Cerebrovascular API Examples
Figure 5. Statins Cardiovascular and Cerebrovascular API Examples
Figure 6. Puri Cardiovascular and Cerebrovascular API Examples
Figure 7. Global Cardiovascular and Cerebrovascular API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Application in 2022
Figure 9. Oral Drugs Examples
Figure 10. Injection Drugs Examples
Figure 11. Global Cardiovascular and Cerebrovascular API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Cardiovascular and Cerebrovascular API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Cardiovascular and Cerebrovascular API Sales Quantity (2018-2029) & (MT)
Figure 14. Global Cardiovascular and Cerebrovascular API Average Price (2018-2029) & (USD/Kg)
Figure 15. Global Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Cardiovascular and Cerebrovascular API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Cardiovascular and Cerebrovascular API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Cardiovascular and Cerebrovascular API Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Cardiovascular and Cerebrovascular API Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Cardiovascular and Cerebrovascular API Average Price by Type (2018-2029) & (USD/Kg)
Figure 30. Global Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Cardiovascular and Cerebrovascular API Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Cardiovascular and Cerebrovascular API Average Price by Application (2018-2029) & (USD/Kg)
Figure 33. North America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Cardiovascular and Cerebrovascular API Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Cardiovascular and Cerebrovascular API Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value Market Share by Region (2018-2029)
Figure 53. China Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Cardiovascular and Cerebrovascular API Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Cardiovascular and Cerebrovascular API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Cardiovascular and Cerebrovascular API Market Drivers
Figure 74. Cardiovascular and Cerebrovascular API Market Restraints
Figure 75. Cardiovascular and Cerebrovascular API Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cardiovascular and Cerebrovascular API in 2022
Figure 78. Manufacturing Process Analysis of Cardiovascular and Cerebrovascular API
Figure 79. Cardiovascular and Cerebrovascular API Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
